APVO
APVO
NASDAQ · Biotechnology

Aptevo Therapeutics Inc

$4.23
+0.27 (+6.82%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +567.8% upside
Low Target $22.50
Average Target $28.25
High Target $48.31
Current Price $4.23
Current
$4.23
Target
$28.25
$22.50 $28.25 avg $48.31
Scenario Analysis
Bear Case
$22.50
431.9%
Low target
Base Case
$28.25
+567.8%
Avg target
Bull Case
$48.31
+1,042.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
Target vs 52W High
$28.25
-97.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%